Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 20784 | 445 | 24.5 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
| 20784 | 1 | NIMESULIDE//CAS 51803 78 2//AULINR | 445 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | NIMESULIDE | authKW | 1650778 | 24% | 23% | 106 |
| 2 | CAS 51803 78 2 | authKW | 617561 | 2% | 100% | 9 |
| 3 | AULINR | authKW | 480325 | 2% | 100% | 7 |
| 4 | ETORICOXIB | authKW | 415084 | 7% | 18% | 33 |
| 5 | MESULIDR | authKW | 343089 | 1% | 100% | 5 |
| 6 | NIMEDR | authKW | 343089 | 1% | 100% | 5 |
| 7 | VALDECOXIB | authKW | 283819 | 5% | 19% | 22 |
| 8 | CLIN PHARMACOKINET BIOAVAI IL | address | 274471 | 1% | 100% | 4 |
| 9 | NISULIDR | authKW | 274471 | 1% | 100% | 4 |
| 10 | NIMESULIDE BETA CYCLODEXTRIN | authKW | 205854 | 1% | 100% | 3 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 2776 | 46% | 0% | 206 |
| 2 | Chemistry, Analytical | 2690 | 34% | 0% | 150 |
| 3 | Biochemical Research Methods | 884 | 16% | 0% | 69 |
| 4 | Chemistry, Medicinal | 171 | 7% | 0% | 29 |
| 5 | Rheumatology | 168 | 4% | 0% | 17 |
| 6 | Chemistry, Multidisciplinary | 128 | 14% | 0% | 61 |
| 7 | Medicine, Research & Experimental | 70 | 6% | 0% | 26 |
| 8 | Medicine, General & Internal | 28 | 5% | 0% | 24 |
| 9 | Toxicology | 27 | 3% | 0% | 14 |
| 10 | Health Policy & Services | 1 | 0% | 0% | 2 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CLIN PHARMACOKINET BIOAVAI IL | 274471 | 1% | 100% | 4 |
| 2 | PHARMACOKINET BIOANALYT RADIOCHEM | 154389 | 1% | 75% | 3 |
| 3 | COX 2 TECHNOL | 137236 | 0% | 100% | 2 |
| 4 | PHYS METHODOL | 123510 | 1% | 60% | 3 |
| 5 | ANALYT J | 68618 | 0% | 100% | 1 |
| 6 | BIOMED NETWORK CIBE P | 68618 | 0% | 100% | 1 |
| 7 | CATTEDRA FARMACOL MED | 68618 | 0% | 100% | 1 |
| 8 | CHESME | 68618 | 0% | 100% | 1 |
| 9 | CLIN PHAMACOL DRUG METAB PHARMACOKINET | 68618 | 0% | 100% | 1 |
| 10 | CONSERVAT ODONTOIATRY | 68618 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | REVISTA BRASILEIRA DE MEDICINA | 11195 | 1% | 4% | 4 |
| 2 | JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 6208 | 7% | 0% | 33 |
| 3 | JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS | 6006 | 7% | 0% | 31 |
| 4 | INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS | 2706 | 1% | 1% | 6 |
| 5 | DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH | 2371 | 2% | 0% | 8 |
| 6 | DRUGS OF TODAY | 2094 | 2% | 0% | 7 |
| 7 | FARMACIA | 1918 | 1% | 1% | 5 |
| 8 | CLINICAL TRIALS JOURNAL | 1734 | 1% | 1% | 3 |
| 9 | ASIAN JOURNAL OF CHEMISTRY | 1733 | 4% | 0% | 19 |
| 10 | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 1467 | 2% | 0% | 9 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | NIMESULIDE | 1650778 | 24% | 23% | 106 | Search NIMESULIDE | Search NIMESULIDE |
| 2 | CAS 51803 78 2 | 617561 | 2% | 100% | 9 | Search CAS+51803+78+2 | Search CAS+51803+78+2 |
| 3 | AULINR | 480325 | 2% | 100% | 7 | Search AULINR | Search AULINR |
| 4 | ETORICOXIB | 415084 | 7% | 18% | 33 | Search ETORICOXIB | Search ETORICOXIB |
| 5 | MESULIDR | 343089 | 1% | 100% | 5 | Search MESULIDR | Search MESULIDR |
| 6 | NIMEDR | 343089 | 1% | 100% | 5 | Search NIMEDR | Search NIMEDR |
| 7 | VALDECOXIB | 283819 | 5% | 19% | 22 | Search VALDECOXIB | Search VALDECOXIB |
| 8 | NISULIDR | 274471 | 1% | 100% | 4 | Search NISULIDR | Search NISULIDR |
| 9 | NIMESULIDE BETA CYCLODEXTRIN | 205854 | 1% | 100% | 3 | Search NIMESULIDE+BETA+CYCLODEXTRIN | Search NIMESULIDE+BETA+CYCLODEXTRIN |
| 10 | LEFUCOXIB | 137236 | 0% | 100% | 2 | Search LEFUCOXIB | Search LEFUCOXIB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | STAREK, M , (2011) REVIEW OF THE APPLICATIONS OF DIFFERENT ANALYTICAL TECHNIQUES FOR COXIBS RESEARCH.TALANTA. VOL. 85. ISSUE 1. P. 8 -27 | 96 | 84% | 4 |
| 2 | STAREK, M , DABROWSKA, M , (2012) CHROMATOGRAPHIC TECHNIQUES IN ANALYSIS OF CYCLOOXYGENASE-2 INHIBITORS IN DRUGS AND BIOLOGICAL SAMPLES.CENTRAL EUROPEAN JOURNAL OF CHEMISTRY. VOL. 10. ISSUE 3. P. 711-730 | 51 | 74% | 3 |
| 3 | RAO, RN , MEENA, S , RAO, AR , (2005) AN OVERVIEW OF THE RECENT DEVELOPMENTS IN ANALYTICAL METHODOLOGIES FOR DETERMINATION OF COX-2 INHIBITORS IN BULK DRUGS, PHARMACEUTICALS AND BIOLOGICAL MATRICES.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 39. ISSUE 3-4. P. 349-363 | 62 | 55% | 40 |
| 4 | EL-SAYED, GO , SABER, AL , (2011) EXTRACTIVE SPECTROPHOTOMETRIC DETERMINATION OF ANTI-INFLAMMATORY DRUG NIMESULIDE IN PHARMACEUTICAL FORMULATIONS AND HUMAN PLASMA.JOURNAL OF FOOD AND DRUG ANALYSIS. VOL. 19. ISSUE 4. P. 429 -436 | 22 | 92% | 1 |
| 5 | RABASSEDA, X , (1996) NIMESULIDE: A SELECTIVE CYCLOOXYGENASE 2 INHIBITOR ANTIINFLAMMATORY DRUG.DRUGS OF TODAY. VOL. 32. ISSUE . P. 1 -23 | 42 | 65% | 42 |
| 6 | RABASSEDA, X , (1996) NIMESULIDE: A SELECTIVE CYCLOOXYGENASE 2 INHIBITOR ANTIINFLAMMATORY DRUG.DRUGS OF TODAY. VOL. 32. ISSUE 5. P. 365 -384 | 42 | 64% | 4 |
| 7 | TUBIC, B , IVKOVIC, B , ZECEVIC, M , VLADIMIROV, S , (2007) SIMULATANEOUS DETERMINATION OF NIMESULIDE AND ITS IMPURITIES IN PHARMACEUTICAL FORMULATIONS BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY.ACTA CHIMICA SLOVENICA. VOL. 54. ISSUE 3. P. 583-590 | 22 | 81% | 10 |
| 8 | CHANDRAN, S , RAVI, P , JADHAV, P , SAHA, R , (2008) A SIMPLE, RAPID, AND VALIDATED LC METHOD FOR THE ESTIMATION OF NIMESULIDE IN HUMAN SERUM AND ITS APPLICATION IN BIOAVAILABILITY STUDIES.ANALYTICAL LETTERS. VOL. 41. ISSUE 13. P. 2437 -2451 | 19 | 90% | 2 |
| 9 | DAVIS, R , BROGDEN, RN , (1994) NIMESULIDE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY.DRUGS. VOL. 48. ISSUE 3. P. 431-454 | 27 | 71% | 159 |
| 10 | DA SILVA, IS , CAPOVILLA, B , FREITAS, KHG , ANGNES, L , (2013) STRATEGIES TO AVOID ELECTRODE FOULING FOR NIMESULIDE DETECTION USING UNMODIFIED ELECTRODES.ANALYTICAL METHODS. VOL. 5. ISSUE 14. P. 3546-3551 | 17 | 71% | 2 |
Classes with closest relation at Level 1 |